Some animal studies show curcumin may improve blood sugar control by increasing GLP-1 release
FDA: Food and Drug Administration
Developed by Novo Nordisk, WEGOVY (semaglutide) is a GLP-1 receptor agonist designed to support sustainable weight loss when paired with a balanced diet and regular physical activity
It is then possible that intake of these nutrients may re-establish an optimal natural balance for the Nrf2 pathway and mitigate COVID-19 severity (Bousquet et al., 2020)
For example, these peptides can enhance your hormone production, regenerative tissue repair, immune system, and overall cellular health
While appetite regulation may begin within the first several days, noticeable weight reduction typically develops over the first few weeks of consistent use